WHO ICTRP trial

GamiGuipi-Tang for Treating Insomnia Disorder: multi-site, randomized…

KCT0003811 · Clinical Research Information Service (CRIS) · Not Recruiting

Key facts

Trial ID KCT0003811
Public title GamiGuipi-Tang for Treating Insomnia Disorder : multi-site, randomized controlled double-blind, comparative clinical trial study
Scientific title GamiGuipi-Tang for Treating Insomnia Disorder : multi-site, randomized controlled double-blind, comparative clinical trial study
Primary sponsor Pusan National University Korean Medicine Hospital
Registry Clinical Research Information Service (CRIS)
Recruitment status Not Recruiting
Study type Interventional Study
Phase Phase3
Countries Korea, Republic of
Conditions Diseases of the nervous system
Interventions Drug : Experimental group: GamiGuiPii-tang (Hangpung Pharmaceutical), 3g*3 times /day, 3 weeks of intermission, oral medication. GamiGui-Bitang (brown granulomicide, Hanpung Pharmaceutical)-Insam, Baeksu, Bokryeong, Yongan meat, Hwanggwi…
Registration date Apr 18, 2019
Target size 96
Registry page cris.nih.go.kr

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations